However, more studies also including verified diagnoses of depression, both types of diabetes, patients from primary care settings, and patients with more severe treatment (i.e. insulin) should be conducted to approach the possibility of a different cut-off more thoroughly. The gene discussed is INS; the disease is depressive disorder.